Search

NY-ESO-1 (161-180)

Cancer/testis antigen 1; NY-ESO-1

Online Inquiry

Specification Technical Data Related Products Customer reviews and Q&A Useful Tools Publications
CAT#ta-027
CASN/A
Synonyms/AliasCancer/testis antigen 1 (161-180); NY-ESO-1 (161-180)
SequenceWITQCFLPVFLAQPPSGQRR
Areas of InterestAntigen-presenting Cells; Cancer Research
Quick Inquiry
×
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Customer Support & Price Inquiry

* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).

Recommended Services

Peptide Synthesis Services

Custom Conjugation Service

Peptide PEGylation

Unusual and Non-natural Amino Acids Modification

cGMP Peptide Service

Peptide CDMO

Peptide API Development

Resource

Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!

Function of spadin in neurological treatment of depression

Tandem P-domain weak inward rectifying K+ (TWIK)-related K+ channel 1 (TREK-1) and TWIK-related acid-sensitive K ...

Function of teriparatide in the treatment of osteoporosis

 Teriparatide is a human parathyroid hormone analog with the same structure as the N-terminal 34 amino acid seque ...

Function of icatibant in hereditary angioedema

 Icatibant, sold under the trade name Firazyr, is a plasma kallikrein inhibitor and the bradykinin B2 receptor an ...

Peptidic Antagonist to CRF2 Receptor–Astressin 2B

 Astressin 2B is a peptidic antagonist to CRF2 (corticotrophin-releasing factor 2) receptor with structure of cyc ...

Function of M871 as a Galanin GAL2 Receptor Antagonist

 Galanin-(2–13)-Glu-His-(Pro)3-(Ala-Leu)2-Ala-amide (M871) is a novel peptide antagonist selectively recognizing ...

Contact Us

USA

Address:

Tel: |

Email:

Germany

Address:

Copyright © 2024 Creative Peptides. All rights reserved.